Expression of TGF-β related Smad proteins in human epithelial skin tumors

International Journal of Oncology

Volumn 14, Issue 6, 1999, Pages 1049-1056

  Lange, Dirk ^a,c   Persson, Urban ^b   Wollina, Uwe ^a   Ten Dijke, Peter ^c   Castelli, Elena ^d   Heldin, Carl Henrik ^c   Funa, Keiko ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^d UNIVERSITY OF PALERMO   (Italy)

Author keywords

Skin tumors; Smad proteins; Transforming growth factor

Indexed keywords

ACTIVIN RECEPTOR 1; BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; DNA BINDING PROTEIN; OSTEOGENIC PROTEIN 1; PROTEIN SERINE THREONINE KINASE; SMAD2 PROTEIN; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN; SMAD3 PROTEIN, HUMAN; SMAD4 PROTEIN; SMAD4 PROTEIN, HUMAN; SMAD6 PROTEIN; SMAD6 PROTEIN, HUMAN; SMAD7 PROTEIN; SMAD7 PROTEIN, HUMAN; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BASAL CELL CARCINOMA; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL STRAIN COS1; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; HUMAN; KERATINOCYTE; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; SIGNAL TRANSDUCTION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

ACTIVIN RECEPTORS, TYPE I; AMINO ACID SEQUENCE; ANIMALS; BONE MORPHOGENETIC PROTEINS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL LINE; COS CELLS; DNA-BINDING PROTEINS; HUMANS; KERATINOCYTES; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0033142116     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Roberts AB and Sporn MB: Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 8: 1-9, 1993.
2. Cárcamo J, Weis FM, Ventura F, Wieser R, Wrana JL, Attisano L and Massagué J: Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin. Mol Cell Biol 14: 3810-3821, 1994.
3. Chen R-H and Derynck R: Homomeric interactions between type II transforming growth factor-β receptor. J Biol Chem 269: 22868-22874, 1994.
4. Wrana JL, Attisano L, Wieser R, Ventura F and Massagué J: Mechanism of activation of the TGF-β receptor. Nature 370: 341-347, 1994.
5. Massagué J, Hata A and Liu F: TGF-β signalling through the Smad pathway. Trends Cell Biol 7: 187-192, 1997.
6. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL and Attisano L: MADR2 maps to 18q21 and encodes a TGF-β regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86: 543-552, 1996.
7. Zhang Y, Feng X-H, Wu R-Y and Derynck R: Receptor associated Mad homologues synergize as effectors of the TGF-β response. Nature 383: 168-172, 1996.
8. Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin C-H, Miyazono K and ten Dijke P: TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 16: 5353-5362, 1997.
9. Hoodless PA, Haerry T, Abdollah S, Stapleton M, O'Connor MB, Attisano L and Wrana JL: MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85: 489-500, 1996.
10. Liu F, Hata A, Baker JC, Doody J, Carcamo J, Harland RM and Massagué J: A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381: 620-623, 1996.
11. Kretzschmar M, Liu F, Hata A, Doody J and Massagué J: The TGF-β family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev 11: 984-995, 1997.
12. Nishimura R, Kato Y, Chen D, Harris SE, Mundy GR and Yoneda T: Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem 273: 1872-1879, 1998.
13. Suzuki A, Chang C, Yingling JM, Wang W-F and Hemmati-Brivanlou A: Smad5 induces ventral fates in Xenopus embryo. Dev Biol 84: 402-405, 1997.
14. Watanabe TK, Suzuki M, Omori Y, Hishigaki H, Horie M, Kanemoto N, Fujiwara T, Nakamura Y and Takahashi E: Cloning and characterization of a novel member of the human MAD gene family. Genomics 42: 446-451, 1997.
15. Lagna G, Hata A, Hammati-Brivanlou A and Massagué J: Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 383: 832-836, 1996.
16. Wu R-Y, Zhang Y, Feng X-H and Derynck R: Heteromeric and homomeric interactions correlate with signalling activity and functional cooperativity of Smad3 and Smad4/DPCA. Mol Cell Biol 17: 2521-2528, 1997.
17. Nakao A, Afrakthe M, Morén A, Nakayama T, Christian JL, Heuchel R, Itho S, Kawabata M, Heldin N-E, Heldin C-H and ten Dijke P: Identification of Smad7, a TGF-β-inducable antagonist of TGF-β signalling. Nature 389: 631-635, 1997.
18. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA Jr, Wrana JL and Falb D: The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGFβ signalling. Cell 89: 1165-1173, 1997.
19. Topper JN, Cai J, Qiu Y, Anderson KR, Xu YY, Deeds JD, Feeley R, Gimeno CJ, Woolf EA, Tayber O, Mays GG, Sampson BA, Schoen FJ, Gimbrone MA Jr and Falb D: Vascular MADs: two novel MAD-related genes selectively inducable by flow in human vascular endothelium. Proc Natl Acad Sci USA 94: 9314-9319, 1997.
20. Hata A, Lo RS, Wotton D, Lagna G and Massagué J: Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature 388: 82-87, 1997.
21. Heldin C-H, Miyazono K and ten Dijke P: TGF-β signalling from cell membrane to nucleus via Smad proteins. Nature 390: 465-471, 1997.
22. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A and Fusenig NE: Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761-771, 1988.
23. Ichijo H, Momose F and Miyazono K: Biological effects and binding properties of transforming growth factor-β on human oral squamous cell carcinoma cells. Exp Cell Res 187: 263-269, 1990.
24. Pulford KA, Gatter KC and Mason DY: The characterization of two monoclonal anti-keratin antibodies and their use in the study of epithelial disorders. Histopathology 9: 825-844, 1985.
25. Franzén P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin C-H and Miyazono K: Cloning of a TGFβ type I receptor that forms a heterodimeric complex with the TGFβ type II receptor. Cell 75: 681-692, 1993.
26. Waltenberger J, Lundin L, Öberg K, Wilander E, Miyazono K, Heldin C-H and Funa K: Involvement of transforming growth factor-β in the formation of fibrotic lesions in carcinoid heart disease. Am J Pathol 142: 71-78, 1993.
27. Waltenberger J, Wanders A, Fellström B, Miyazono K, Heldin C-H and Funa K: Induction of transforming growth factor-β during cardiac allograft rejection. J Immunol 151: 1147-1157, 1993.
28. Wollina U, Lange D, Funa K and Paus R: Expression of transforming growth factor β isoforms and their receptors during hair growth phases in mice. Histol Histopathol 11: 431-436, 1996.
29. Furue M, Kato M, Nakamura K, Nashiro K, Kikuchi K, Okochi H, Miyazono K and Tamaki K: Dysregulated expression of transforming growth factor β and its type-I and type-II receptors in basal-cell carcinoma. Int J Cancer 71: 505-509, 1997.
30. Wollina U, Lange D, ten Dijke P, Heldin C-H and Funa K: Eccrine sweat glands - expression of TGF-β and BMP type I receptors and Smad proteins. Acta Derm Venereol (In press).
31. Tam BY, Germain L and Philip A: TGF-β receptor expression on human keratinocytes: a 150 kDa GPI-anchored TGF-β1 binding protein forms a heteromeric complex with type I and type II receptors. J Cell Biochem 70: 573-586, 1998.
32. Amendt C, Schirmacher P, Weber H and Blessing M: Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development. Oncogene 17: 25-34, 1998.
33. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Toftgard R, Chevenix-Trench G, Wainwright B and Bale AE: Mutations of the human homologue of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85: 841-851, 1996.
34. De Caestecker MP, Hemmati P, Larisch-Block S, Ajmera R, Roberts AB and Lechleider RJ: Characterization of functional domains within Smad4/DPC4. J Biol Chem 272: 13690-13696, 1997.
35. Riggins GJ, Thiagalingam S, Rozenblum E, Weinstein CL, Kern SE, Hamilton SR, Willson JK, Markowitz SD, Kinzler KW and Vogelstein B: Mad-related genes in the human. Nat Genet 13: 347-349, 1996.
36. Riggins GJ, Kinzler KW, Vogelstein B and Thiagalingam S: Frequency of Smad gene mutations in human cancers. Cancer Res 57: 2578-2580, 1997.
37. Chen Y, Lebrun JJ and Vale W: Regulation of transforming growth factor β- and activin-induced transcription by mammalian MAD proteins. Proc Natl Acad Sci USA 93: 12992-12997, 1996.
38. Woo KM, Lee G, Kook JK and Min BM: Conversion of normal human oral keratinocytes to tumorigenic cells is associated with the acquisition of resistance to TGF-β. Int J Oncol 12: 833-839, 1998.
39. Glick AB, Danielpour D, Morgan D, Sporn MB and Yuspa SH: Induction and autocrine-receptor binding of transforming growth factor-β2 during terminal differentiation of primary mouse keratinocytes. Mol Endocrinol 4: 46-52, 1990.
40. Falanga V, Gerhardt CO, Dasch JR, Takehara K and Ksander GA: Skin distribution and differential expression of transforming growth factor β1 and β2. J Dermatol Sci 3: 131-136, 1992.
41. Schmid P, Cox D, Bilbe G, McMaster G, Morrison C, Stahelin H, Luscher N and Seiler W: TGF-βs and TGF-β type-II receptor in the human epidermis: differential expression in acute and chronic wounds. J Pathol 171: 191-197, 1993.
42. Rudnicka L, Varga J, Christiano AM, Iozzo RV, Jimenez SA and Uitto J: Elevated expression of type-VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-β. J Clin Invest 93: 1709-1715, 1994.
43. Kato M, Ihizaki A, Hellmann U, Wernstedt C, Kyogoku M, Miyazano K, Heldin H-C and Funa K: A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-β and insulin-like growth factor binding protein-6, in a calcium- and cell-densitity-dependent manner. J Biol Chem 270: 12373-12379, 1995.
44. Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA and Lodish HF: Transforming growth factor β-induced phosphorylation of Samd3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci USA 94: 10669-10674, 1997.
45. Heenen M: Cell cycle regulation and abnormalities in epidermal tumors. Ann Dermatol Venereol 124: 452-456, 1997.
46. Ko TC, Yu W, Sakai T, Sheng H, Shao J, Beauchamp RD and Thompson EA: TGF-β effects on proliferation of rat intestinal cells are due to inhibition of cyclin D1 expression. Oncogene 16: 3445-3454, 1998.
47. Stone DM, Hynes M, Armanini M, Swanson TA, Gu Q, Johnson RL, Scott MP, Pennica D, Goddard A, Phillips H, Noll M, Hooper JE, de Sauvage F and Rosenthal A: The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature 384: 129-134, 1996.
48. Ting-Berreth SA and Chuong CM: Local delivery of TGFβ2 can substitute for placode epithelium to induce mesenchymal condensation during skin appendage morphogenesis. Dev Biol 179: 347-359, 1996.
49. Goodrich LV, Johnson RL, Milenkovic L, McMahon JA and Scott MP: Conservation of the hedgehog/patched signaling pathway from flies to mice: induction of a mouse patched gene by Hedgehog. Genes Dev 10: 301-312, 1996.
50. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH and Kern SE: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353, 1996.
51. Aszterbaum M, Rothman A, Johnson RL, Fisher M, Xie J, Bonifas JM, Zhang X, Scott MP and Epstein EH Jr: Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol 110: 885-888, 1998.
52. Unden AB, Holmber E, Lundh-Rozell B, Stahle-Backdahl M, Zaphiropoulos PG, Toftgard R and Vorechovsky I: Mutations in the human homologue of Drosophila patched (PCTH) in basal cell carcinomas and the Gorlin syndrome: different in vivo mechanisms of PCTH activation. Cancer Res 56: 4562-4565, 1996.
53. Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, Bonifas JM, Lam CW, Hynes M, Goddard A, Rosenthal A, Epstein EH Jr and de Sauvage FJ: Activating smoothened mutations in sporadic basal-cell carcinoma. Nature 391: 90-92, 1998.
54. Chen Y and Struhl G: Dual role for patched in sequestering and transducing Hegdehog. Cell 87: 553-563, 1996.
55. Vorechovsky I, Unden AB, Sandstedt B, Toftgart R and Stahle-Bachdahl M: Trichoepitheliomas contain somatic mutations in the overexpressed PTCH-gene: support for a gatekeeper mechanism in tumorigenesis. Cancer Res 57: 4677-4681, 1997.